Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021.
British Columbia
COVID-19
Canada
January–April 2021. Emerg Infect Dis. 2021 Nov [date cited]. https://doi.org/10.3201/eid2711.211190
Jassem AN
Joffres Y
Noftall K
SARS-CoV-2
Sbihi H
Suggested citation for this article: Hogan CA
Tyson JR
coronavirus disease
et al. Rapid increase in SARS-CoV-2 P.1 lineage leading to codominance with B.1.1.7 lineage
public health
respiratory infections
severe acute respiratory syndrome coronavirus 2
testing
variant of concern
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
pubmed:
14
8
2021
medline:
28
10
2021
entrez:
13
8
2021
Statut:
ppublish
Résumé
Several severe acute respiratory syndrome coronavirus 2 variants of concern (VOCs) emerged in late 2020; lineage B.1.1.7 initially dominated globally. However, lineages B.1.351 and P.1 represent potentially greater risk for transmission and immune escape. In British Columbia, Canada, B.1.1.7 and B.1.351 were first identified in December 2020 and P.1 in February 2021. We combined quantitative PCR and whole-genome sequencing to assess relative contribution of VOCs in nearly 67,000 infections during the first 16 weeks of 2021 in British Columbia. B.1.1.7 accounted for <10% of screened or sequenced specimens early on, increasing to >50% by week 8. P.1 accounted for <10% until week 10, increased rapidly to peak at week 12, and by week 13 codominated within 10% of rates of B.1.1.7. B.1.351 was a minority throughout. This rapid expansion of P.1 but suppression of B.1.351 expands our understanding of population-level VOC patterns and might provide clues to fitness determinants for emerging VOCs.
Identifiants
pubmed: 34388358
doi: 10.3201/eid2711.211190
pmc: PMC8544957
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2802-2809Références
Emerg Infect Dis. 2021 Jun;27(6):1673-1676
pubmed: 33784237
JAMA. 2021 Mar 16;325(11):1037-1038
pubmed: 33595644
N Engl J Med. 2021 Jun 10;384(23):2212-2218
pubmed: 33882219
Science. 2021 Mar 12;371(6534):1152-1153
pubmed: 33514629
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Viruses. 2021 Apr 29;13(5):
pubmed: 33946747
Wellcome Open Res. 2021 May 19;6:121
pubmed: 34095513
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):95-99
pubmed: 33476315
Nat Med. 2021 Apr;27(4):717-726
pubmed: 33664494
Lancet Infect Dis. 2021 Sep;21(9):1246-1256
pubmed: 33857406